[go: up one dir, main page]

MX2016009243A - Métodos de mutagénesis. - Google Patents

Métodos de mutagénesis.

Info

Publication number
MX2016009243A
MX2016009243A MX2016009243A MX2016009243A MX2016009243A MX 2016009243 A MX2016009243 A MX 2016009243A MX 2016009243 A MX2016009243 A MX 2016009243A MX 2016009243 A MX2016009243 A MX 2016009243A MX 2016009243 A MX2016009243 A MX 2016009243A
Authority
MX
Mexico
Prior art keywords
nuclease
spliced
locus
methods
genomic locus
Prior art date
Application number
MX2016009243A
Other languages
English (en)
Inventor
M Rothberg Jonathan
Xu Tian
Original Assignee
Lam Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lam Therapeutics Inc filed Critical Lam Therapeutics Inc
Publication of MX2016009243A publication Critical patent/MX2016009243A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/50—Methods for regulating/modulating their activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

En algunas modalidades, los aspectos de la descripción proveen métodos y composiciones que son útiles para modificar (por ejemplo, mutar) uno o más alelos de un locus genómico dentro de una célula; en algunas modalidades, los métodos y composiciones descritos en la presente implican producir una molécula de ARN empalmada quimérica que incluye un exón transcrito empalmado a un segmento de ARN de interacción con la nucleasa; en algunas modalidades, el ARN empalmado quimérico guía una enzima que modifica el ADN (por ejemplo, una nucleasa) hacia un locus genómico en una célula, resultando en la modificación del locus.
MX2016009243A 2014-01-14 2015-01-14 Métodos de mutagénesis. MX2016009243A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927458P 2014-01-14 2014-01-14
PCT/US2015/011425 WO2015108993A1 (en) 2014-01-14 2015-01-14 Mutagenesis methods

Publications (1)

Publication Number Publication Date
MX2016009243A true MX2016009243A (es) 2017-03-08

Family

ID=52432989

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009243A MX2016009243A (es) 2014-01-14 2015-01-14 Métodos de mutagénesis.

Country Status (11)

Country Link
US (1) US20150197759A1 (es)
EP (1) EP3094729A1 (es)
JP (1) JP2017502683A (es)
KR (1) KR20160128306A (es)
CN (1) CN106459996A (es)
AU (1) AU2015206510A1 (es)
CA (1) CA2936936A1 (es)
IL (1) IL246762A0 (es)
MX (1) MX2016009243A (es)
RU (1) RU2016133286A (es)
WO (1) WO2015108993A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734621B1 (en) 2011-07-22 2019-09-04 President and Fellows of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
DK3066201T3 (en) 2013-11-07 2018-06-06 Editas Medicine Inc CRISPR-RELATED PROCEDURES AND COMPOSITIONS WITH LEADING GRADES
US20150166982A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
EP4079847A1 (en) 2014-07-30 2022-10-26 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
JP7067793B2 (ja) 2015-10-23 2022-05-16 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸塩基編集因子およびその使用
CA3009190A1 (en) * 2015-12-29 2017-07-06 Monsanto Technology Llc Novel crispr-associated transposases and uses thereof
IL264565B2 (en) 2016-08-03 2024-07-01 Harvard College Adenosine nucleobase editors and uses thereof
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
EP3592777A1 (en) 2017-03-10 2020-01-15 President and Fellows of Harvard College Cytosine to guanine base editor
SG11201908658TA (en) 2017-03-23 2019-10-30 Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
JP2020534795A (ja) 2017-07-28 2020-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ ファージによって支援される連続的進化（ｐａｃｅ）を用いて塩基編集因子を進化させるための方法および組成物
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
EP3724214A4 (en) 2017-12-15 2021-09-01 The Broad Institute Inc. SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
WO2020154500A1 (en) 2019-01-23 2020-07-30 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191246A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
RU2722934C1 (ru) * 2019-06-11 2020-06-05 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Средство разрезания днк на основе cas9 белка из бактерии pasteurella pneumotropica
WO2021072328A1 (en) 2019-10-10 2021-04-15 The Broad Institute, Inc. Methods and compositions for prime editing rna
GB2614813B (en) 2020-05-08 2025-05-07 Harvard College Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
US20090113561A1 (en) * 2004-11-26 2009-04-30 Frankgen Biotechnologie Ag Gene trap cassettes for random and targeted conditional gene inactivation
AU2005331864A1 (en) * 2005-05-14 2006-11-23 Fudan University Piggybac as a tool for genetic manipulation and analysis in vertebrates
EP2166107A1 (en) * 2008-09-12 2010-03-24 TaconicArtemis GmbH Lentiviral vectors for the expression of shRNA
US9790489B2 (en) * 2009-10-26 2017-10-17 Chang Gung University Method for performing genetic modification under a drug-free environment and components thereof
US9637739B2 (en) * 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
US20160046961A1 (en) 2012-05-25 2016-02-18 Emmanuelle Charpentier Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
US9234213B2 (en) * 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
DK3066201T3 (en) * 2013-11-07 2018-06-06 Editas Medicine Inc CRISPR-RELATED PROCEDURES AND COMPOSITIONS WITH LEADING GRADES
US20150191744A1 (en) * 2013-12-17 2015-07-09 University Of Massachusetts Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling
JP2017509350A (ja) * 2014-04-03 2017-04-06 マサチューセッツ インスティテュート オブ テクノロジー ガイドｒｎａの生成のための方法および組成物

Also Published As

Publication number Publication date
WO2015108993A8 (en) 2016-06-02
KR20160128306A (ko) 2016-11-07
CN106459996A (zh) 2017-02-22
AU2015206510A1 (en) 2016-08-04
JP2017502683A (ja) 2017-01-26
CA2936936A1 (en) 2015-07-23
IL246762A0 (en) 2016-08-31
WO2015108993A1 (en) 2015-07-23
US20150197759A1 (en) 2015-07-16
RU2016133286A (ru) 2018-02-20
EP3094729A1 (en) 2016-11-23

Similar Documents

Publication Publication Date Title
MX2016009243A (es) Métodos de mutagénesis.
AU2017248555B2 (en) Closed nucleic acid structures
EP3216867A4 (en) Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
EP3728589A4 (en) CHEMICAL GENOMIC ENGINEERING MOLECULES AND PROCESSES
PH12017502026A1 (en) Nuclease-mediated regulation of gene expression
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
MX2016013982A (es) Transformacion de maiz haploide.
NZ769992A (en) Non-human animals having a humanized cluster of differentiation 47 gene
HK1256817A1 (zh) 用於基因组编辑的组合物和方法
AU2015205612A8 (en) Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines
GB2533173A (en) De Novo synthesized gene libraries
MX2022000378A (es) Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados.
EP3194570A4 (en) Methods and compositions for nuclease-mediated genome engineering and correction in hematopoietic stem cells
WO2013188522A3 (en) Methods and compositions for generating conditional knock-out alleles
EP4234703A3 (en) Genome engineering
MY193116A (en) Chiral design
MX2015014487A (es) Modificación dirigida del genoma de rata.
MX2013010911A (es) Metodos para producir un locus de rasgo transgenico complejo.
MX2019007248A (es) Enzimas de polimerizacion para reacciones de secuenciacion.
WO2015187825A3 (en) Compositions and methods for modulating dysferlin expression
AU2015315168A8 (en) Targeted mutagenesis in spirulina
MX349339B (es) Gen y variaciones asociadas con el fenotipo bm1, marcadores moleculares, y su uso.
EP3239098A4 (en) Method for catalytically oxidizing hydrogen chloride to prepare chlorine gas
WO2012136909A3 (fr) HYDROGELS THIXOTROPES À BASE α-LACTALBUMINE, LEUR PROCÉDÉ DE PRÉPARATION ET LEURS UTILISATIONS
PH12017501094A1 (en) Parental rnai suppression of chromatin remodeling genes to control coleopteran pests